Nreal

N-Real is a computational biology company specializing in the de novo design of functional proteins using artificial intelligence and machine learning. Based in Israel, the company leverages structural biology and advanced algorithms to create novel proteins with optimized properties for therapeutic, diagnostic, and industrial applications. Their platform aims to overcome the limitations of natural proteins by designing molecules with enhanced stability, specificity, and binding affinity. N-Real is currently in the pre-clinical stage, focusing on developing its core technology and establishing partnerships for drug discovery and protein engineering.